RELATED APPLICATION(S)

This application claims the benefit of U.S. Provisional Application No. 60/731,021, filed on Oct. 27, 2005. The entire teachings of the above application(s) are incorporated herein by reference.

BACKGROUND OF THE INVENTION

Antioxidants are employed to prevent oxidation in a wide range of materials, for example, plastics, elastomers, lubricants, petroleum based products (lubricants, gasoline, aviation fuels, and engine oils), cooking oil, cosmetics, processed food products, and the like. While many small molecule antioxidants exist, there is a continuing need for new antioxidants that have improved properties.

The commercial use of triaryl phophites in latex is well known. Triaryl phophites containing alkyl-substituted phenyl rings have been found to be effective synthetic latex stabilizers. However, there is a continuing need for antioxidants with higher antioxidant activity and higher thermal stability.

SUMMARY OF THE INVENTION

The present invention relates to high performance, sterically hindered, phenol and phosphite based macromolecular antioxidants. In certain embodiments, the sterically hindered, phenol and phosphite based macromolecules of the present invention have enhanced antioxidant activity and better thermal stability compared to commercially available antioxidants.

In particular, the present invention pertains to sterically hindered phenol and phosphite based compounds represented by a formula selected from I-III: [Image Omitted]

R is: [Image Omitted]

R₁and R₂in each occurrence, independently is an optionally substituted alkyl, an optionally substituted aryl or an optionally substituted aralkyl.

X and Y in each occurrence, independently is a bond, â€”Oâ€”, â€”NHâ€”, â€”C(O)NHâ€”, â€”NHC(O)â€”, â€”C(O)Oâ€”, â€”OC(O)â€” or â€”CH₂â€”.

n and m in each occurrence, is independently 0 or a positive integer.

i and j in each occurrence, independently is 0, 1, 2, 3 or 4.

Râ€³ is an optionally substituted alkyl.

In another embodiment, the present invention pertains to methods of preventing oxidation. The method comprises combining an oxidizable material with a compound represented by a structural formula selected from I-III.

In yet another embodiment, the present invention pertains to methods for preparing sterically hindered phenol and phosphite based compound, having a formula selected from I-III. The method comprises combining a phenol containing compound with a phosphorous containing compound, such as, phosphorous trichloride in a suitable solvent under conditions suitable for reaction of the phenol containing compound with the phosphorous containing compound.

In yet another embodiment the present invention pertains to the use of the disclosed compounds as antioxidants in a wide range of materials including, but not limited to, food, plastics, elastomers, composites and petroleum based products.

The compounds of the invention provide significant oxidative resistance and thermal stability. The compounds of the invention generally have higher oxidative induction time, higher thermal stability and lower change of Melt flow or viscosity than commercially available antioxidants Without wishing to be bound by theory it is believed that the enhanced molecular activity comes from the synergistic chemistry between the two main integral components (phenolic and phosphite components) of these macromolecular antioxidants.

In certain embodiments, the compounds disclosed herein, do not discolor the substance to which they are added. In certain other embodiments the compounds disclosed herein impart fewer odors to the substance to which they are added than currently available antioxidants. In certain other embodiments, the disclosed compounds provide enhanced oven aging properties to organic materials subject to attack by heat and oxygen. In certain other embodiments the disclosed compounds have higher antioxidant activity and higher thermal stability than antioxidants which are currently known or used in the art.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1, is a comparison of the Oxidative Induction Time (OIT) of one embodiment of the invention, namely, tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphate, versus commercially available IrganoxÂ®.

FIG. 2 is the Fourier Transform Infrared (FT-IR) spectrum of tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphate of the invention.

FIG. 3 is the Ultraviolet (UV) spectrum of tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphate of the invention.

FIG. 4 is the Thermogravimetric Analysis (TGA) of tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphate of the invention.

DETAILED DESCRIPTION OF THE INVENTION

The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.

In one embodiment, the present invention pertains to sterically hindered phenol and phosphite based compounds, represented by a formula selected from I-III: [Image Omitted]

R is: [Image Omitted]

R₁and R₂in each occurrence, independently is an optionally substituted alkyl, optionally substituted aryl or optionally substituted aralkyl. In one embodiment, each R₁and R₂are independently an optionally substituted alkyl. In another embodiment, each R₁and R₂are independently a C1-C6 alkyl.

In one embodiment R is: [Image Omitted]

In another embodiment R is: [Image Omitted]

In yet another embodiment R is: [Image Omitted]

X and Y in each occurrence independently is a bond, â€”Oâ€”, â€”NHâ€”, â€”C(O)NHâ€”, â€”NHC(O)â€”, â€”C(O)Oâ€”, â€”OC(O)â€” or â€”CH₂â€”. In one embodiment, X and Y in each occurrence independently is a bond or â€”CH₂â€”. In another embodiment. X and Y in each occurrence independently is a bond, â€”Oâ€” or â€”CH₂â€”. In yet another embodiment, X and Y in each occurrence independently is a bond, â€”NHâ€” or â€”CH₂â€”. In yet another embodiment, X and Y in each occurrence independently is a bond, â€”C(O)NHâ€” or â€”CH₂â€”. In yet another embodiment, X and Y in each occurrence independently is a bond, â€”NHC(O)â€”, or â€”CH₂â€”. In yet another embodiment, X and Y in each occurrence independently is a bond, â€”C(O)Oâ€” or â€”CH₂â€”. In yet another embodiment, X and Y in each occurrence independently is a bond, â€”OC(O)â€” or â€”CH₂â€”.

n and m in each occurrence independently is 0 or a positive integer. In one embodiment, n and m in each occurrence independently is 0 to 18. In another embodiment, n and m in each occurrence independently is 0 to 12. In yet another embodiment, n and m are in each occurrence independently is 0 to 6.

i and j in each occurrence independently is 0, 1, 2, 3 or 4. In one embodiment i and j in each occurrence independently is 0, 1 or 2. In a particular embodiment, i is 0. In another particular embodiment j is 2.

Râ€³ is an optionally substituted alkyl. In one embodiment Râ€³ is C1-C6 alkyl.

In one embodiment the present invention pertains to compounds represented by structural formula I.

In one embodiment the present invention pertains to compounds represented by structural formula II.

In one embodiment the present invention pertains to compounds represented by structural formula III.

In a particular embodiment, for compounds of the present invention represented by structural formulas I-III, R is: [Image Omitted]
and n and m in each occurrence independently is 0 to 12, and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R, n and m are as described immediately above, and R₁and R₂in each occurrence, independently is an optionally substituted alkyl; i and j in each occurrence independently is 0, 1 or 2; and the remainder of the variables are as described above for structural formulas I-III.

In yet another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i and j are as described immediately above, and R is: [Image Omitted]
n and m in each occurrence, independently is 0 to 6; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”Oâ€” or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”NHâ€” or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”C(O)NHâ€” or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”NHC(O)â€”, or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i,j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”C(O)Oâ€” or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In another particular embodiment, for compounds of the present invention represented by structural formulas I-III, R₁, R₂, i, j, R, n and m are as described immediately above, and X and Y in each occurrence, independently is a bond, â€”OC(O)â€” or â€”CH₂â€”; and the remainder of the variables are as described above for structural formulas I-III.

In an additional embodiment, for formulas I-III R is: [Image Omitted]

n and m in each occurrence, independently is 0 or a positive integer. In one embodiment, n and m in each occurrence, independently is 0 to 18. In another embodiment, n and m in each occurrence, independently is 0 to 12. In yet another embodiment, n and m in each occurrence, independently is 0 to 6.

i and j in each occurrence, independently is 0, 1, 2, 3 or 4. In one embodiment, i and j in each occurrence, independently is 0, 1 or 2. In a particular embodiment, i is 0. In another particular embodiment, j is 2.

Zâ€² is â€”C(O)Oâ€”, â€”OC(O)â€”, â€”C(O)NHâ€”, â€”NHC(O)â€”, â€”NHâ€”, â€”CHâ• Nâ€”, â€”C(O)â€”, â€”Oâ€”, â€”Sâ€”, â€”C(O)OC(O)â€” or a bond. In one embodiment, Zâ€² is â€”C(O)Oâ€”. In another embodiment, Zâ€² is â€”OC(O)â€”. In yet another embodiment, Zâ€² is â€”C(O)NHâ€”. In yet another embodiment, Zâ€² is â€”NHC(O)â€”. In yet another embodiment, Zâ€² is â€”NHâ€”. In yet another embodiment, Zâ€² is â€”CHâ• Nâ€”. In yet another embodiment, Zâ€² is â€”C(O)â€”. In yet another embodiment, Zâ€² is â€”Oâ€”. In yet another embodiment, Zâ€² is â€”Sâ€”. In yet another embodiment, Zâ€² is â€”C(O)OC(O)â€”. In yet another embodiment, Zâ€² is a bond.

Râ€² is an optionally substituted C1-C6 alkyl, â€”OH, â€”NH₂, â€”SH, an optionally substituted aryl, an ester or [Image Omitted]

wherein at least one Râ€² adjacent to the â€”OH group is an optionally substituted bulky alkyl group (e.g., butyl, sec-butyl, tert-butyl, 2-propyl, 1,1-dimethylhexyl, and the like).

Râ€²₁is an optionally substituted C1-C6 alkyl, an optionally substituted aryl, an optionally substituted aralkyl, â€”OH, â€”NH₂, â€”SH, or C1-C6 alkyl ester wherein at least one R₁adjacent to the â€”OH group is a bulky alkyl group (e.g., butyl, sec-butyl, tert-butyl, 2-propyl, 1,1-dimethylhexyl, and the like).).

Râ€²₂is an optionally substituted C1-C6 alkyl, an optionally substituted aryl, an optionally substituted aralkyl, â€”OH, â€”NH₂, â€”SH, or ester.

Xâ€² is â€”C(O)Oâ€”, â€”OC(O)â€”, â€”C(O)NHâ€”, â€”NHC(O)â€”, â€”NHâ€”, â€”CHâ• Nâ€”, â€”C(O)â€”, â€”Oâ€”, â€”Sâ€”, â€”C(O)OC(O)â€” or a bond. In one embodiment Xâ€² is â€”C(O)Oâ€”. In another embodiment Xâ€² is â€”OC(O)â€”. In yet another embodiment Xâ€² is â€”C(O)NHâ€”. In yet another embodiment Xâ€² is â€”NHC(O)â€”. In yet another embodiment Xâ€² is â€”NHâ€”. In yet another embodiment Xâ€² is â€”CHâ• Nâ€”. In yet another embodiment Xâ€² is â€”C(O)â€”. In yet another embodiment Xâ€² is â€”Oâ€”. In yet another embodiment Xâ€² is â€”Sâ€”. In yet another embodiment Xâ€² is â€”C(O)OC(O)â€”. In yet another embodiment Xâ€² is a bond.

Mâ€² is H, an optionally substituted aryl, an optionally substituted C1-C20 linear or branched alkyl chain with or without any functional group anywhere in the chain, or [Image Omitted]
o is 0 or a positive integer. Preferably o is 0 to 18. More preferably o is 0 to 12. Even more preferably o is 0 to 6.

In yet another embodiment, for formulas I-III R is: [Image Omitted]

Râ€²₂is C1-C6 alkyl, â€”OH, â€”NH₂, â€”SH, aryl, ester, aralkyl or [Image Omitted]

wherein at least one Râ€²₂is â€”OH, and the values and preferred values for the remainder of the variables for R are as described immediately above.

In yet another embodiment, the present invention relates to a compound of formula I-III, wherein M is [Image Omitted]

Wherein p is 0, 1, 2, 3 or 4; and the values and preferred values for the remainder of the variables are as described above for formulas I-III.

The term â€œalkylâ€ as used herein means a saturated straight-chain, branched or cyclic hydrocarbon. When straight-chained or branched, an alkyl group is typically C1-C8, more typically C1-C6; when cyclic, an alkyl group is typically C3-C12, more typically C3-C7 alkyl ester. Examples of alkyl groups include methyl, ethyl, n-propyl, iso-propyl, h-butyl, sec-butyl and tert-butyl and 1,1-dimethylhexyl.

The term â€œalkoxyâ€ as used herein is represented by â€”OR**, wherein R** is an alkyl group as defined above.

The term â€œacylâ€ as used herein is represented by â€”C(O)R**, wherein R** is an alkyl group as defined above.

The term â€œalkyl esterâ€ as used herein means a group represented by â€”C(O)OR**, where R** is an alkyl group as defined above.

The term â€œaromatic groupâ€ used alone or as part of a larger moiety as in â€œaralkylâ€ , includes carbocyclic aromatic rings and heteroaryl rings. The term â€œaromatic groupâ€ may be used interchangeably with the terms â€œarylâ€ , â€œaryl ringâ€ â€œaromatic ringâ€ , â€œaryl groupâ€ and â€œaromatic groupâ€ .

Carbocyclic aromatic ring groups have only carbon ring atoms (typically six to fourteen) and include monocyclic aromatic rings such as phenyl and fused polycyclic aromatic ring systems in which a carbocyclic aromatic ring is fused to one or more aromatic rings (carbocyclic aromatic or heteroaromatic). Examples include 1-naphthyl, 2-naphthyl, 1-anthracyl and 2-anthracyl. Also included within the scope of the term â€œcarbocyclic aromatic ringâ€ , as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic), such as in an indanyl, phthalimidyl, naphthimidyl, phenanthridinyl, or tetrahydronaphthyl, where the radical or point of attachment is on the aromatic ring.

The term â€œheteroarylâ€ , â€œheteroaromaticâ€ , â€œheteroaryl ringâ€ , â€œheteroaryl groupâ€ and â€œheteroaromatic groupâ€ , used alone or as part of a larger moiety as in â€œheteroaralkylâ€ refers to heteroaromatic ring groups having five to fourteen members, including monocyclic heteroaromatic rings and polycyclic aromatic rings in which a monocyclic aromatic ring is fused to one or more other aromatic ring (carbocyclic aromatic or heteroaromatic). Heteroaryl groups have one or more ring heteroatoms. Examples of heteroaryl groups include 2-furanyl, 3-furanyl, N-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-oxadiazolyl, 5-oxadiazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 3-pyrazolyl, 4-pyrazolyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 3-pyridazinyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-triazolyl, 5-triazolyl, tetrazolyl, 2-thienyl, 3-thienyl, carbazolyl, 2-benzothienyl, 3-benzothienyl, 2-benzofuranyl, 3-benzofuranyl, 2-indolyl, 3-indolyl, 2-quinolinyl, 3-quinolinyl, 2-benzothiazole, 2-benzooxazole, 2-benzimidazole, 2-quinolinyl, 3-quinolinyl, 1-isoquinolinyl, 3-quinolinyl, 1-isoindolyl and 3-isoindolyl. Also included within the scope of the term â€œheteroarylâ€ , as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic), where the radical or point of attachment is on the aromatic ring.

The term â€œheteroatomâ€ means nitrogen, oxygen, or sulfur and includes any oxidized form of nitrogen and sulfur, and the quaternized form of any basic nitrogen. Also the term â€œnitrogenâ€ includes a substitutable nitrogen of a heteroaryl or non-aromatic heterocyclic group. As an example, in a saturated or partially unsaturated ring having 0-3 heteroatoms selected from oxygen, sulfur or nitrogen, the nitrogen may be N (as in 3,4-dihydro-2H-pyrrolyl), NH (as in pyrrolidinyl) or NRâ€³ (as in N-substituted pyrrolidinyl), wherein Râ€³ is a suitable substituent for the nitrogen atom in the ring of a non-aromatic nitrogen-containing heterocyclic group, as defined below.

An â€œaralkyl groupâ€ , as used herein is an alkyl groups substituted with an aryl group as defined above.

An optionally substituted aryl group as defined herein may contain one or more substitutable ring atoms, such as carbon or nitrogen ring atoms. Examples of suitable substituents on a substitutable ring carbon atom of an aryl group include â€”OH, C1-C3 alkyl, C1-C3 haloalkyl, â€”NO₂, C1-C3 alkoxy, C1-C3 haloalkoxy, â€”CN, â€”NH₂, C1-C3 alkylamino, C1-C3 dialkylamino, â€”C(O)NH₂, â€”C(O)NH(C1-C3 alkyl), â€”C(O)(C1-C3 alkyl), â€”NHC(O)H, â€”NHC(O)(C1-C3 alkyl), â€”C(O)N(C1-C3 alkyl)₂, â€”NHC(O)O-(C1-C3 alkyl), â€”C(O)OH, â€”C(O)O-(C1-C3 alkyl), â€”NHC(O)NH₂, â€”NHC(O)NH(C1-C3 alkyl), â€”NHC(O)N(C1-C3 alkyl)₂, â€”SO₂NH₂â€”SO₂NH(C1-C3alkyl), â€”SO₂N(C1-C3alkyl), NHSO₂H or NHSO₂(C1-C3 alkyl). Preferred substituents on aryl groups are as defined throughout the specification. In certain embodiments optionally substituted aryl groups are unsubstituted

Examples of suitable substituents on a substitutable ring nitrogen atom of an aryl group include C1-C3 alkyl, NH₂, C1-C3 alkylamino, C1-C3 dialkylamino, â€”C(O)NH₂, â€”C(O)NH(C1-C3 alkyl), â€”C(O)(C1-C3 alkyl), â€”CO₂R**, â€”C(O)C(O)R**, â€”C(O)CH₃, â€”C(O)OH, â€”C(O)O-(C1-C3 alkyl), â€”SO₂NH₂â€”SO₂NH(C1-C3alkyl), â€”SO₂N(C1-C3alkyl)₂, NHSO₂H, NHSO₂(C1-C3 alkyl), â€”C(â• S)NH₂, â€”C(â• S)NH(C1-C3 alkyl), â€”C(â• S)N(C1-C3 alkyl)₂, â€”C(â• NH)â€”N(H)₂, â€”C(â• NH)â€”NH(C1-C3 alkyl) and â€”C(â• NH)â€”N(C1-C3 alkyl)₂,

An optionally substituted alkyl group as defined herein may contain one or more substituents. Examples of suitable substituents for an alkyl group include those listed above for a substitutable carbon of an aryl and the following: â• O, â• S, â• NNHR**, â• NN(R**)₂, â• NNHC(O)R**, â• NNHCO₂(alkyl), â• NNHSO₂(alkyl), â• NR**, spiro cycloalkyl group or fused cycloalkyl group. R** in each occurrence, independently is â€”H or C1-C6 alkyl. Preferred substituents on alkyl groups are as defined throughout the specification. In certain embodiments optionally substituted alkyl groups are unsubstituted.

A â€œspiro cycloalkylâ€ group is a cycloalkyl group which shares one ring carbon atom with a carbon atom in an alkylene group or alkyl group, wherein the carbon atom being shared in the alkyl group is not a terminal carbon atom.

Without wishing to be bound by any theory or limited to any mechanism it is believed that macromolecular antioxidants of the present invention exploit the differences in activities (ks, equilibrium constant) of, for example, homo- or hetero-type antioxidant moieties. Antioxidant moieties include, for example, hindered phenolic groups, unhindered phenolic groups, aminic groups and thioester groups, etc. of which there can be one or more present in each macromolecular antioxidant molecule. As used herein a homo-type antioxidant macromolecule comprises antioxidant moieties which are all same, for example, hindered phenolic, â€”OH groups. As used herein a hetero-type antioxidant macromolecule comprises at least one different type of moiety, for example, hindred phenolic and aminic groups in the one macromolecule.

This difference in activities can be the result of, for example, the substitutions on neighboring carbons or the local chemical or physical environment (for example, due to electrochemical or stereochemical factors) which can be due in part to the macromolecular nature of molecules.

In one embodiment of the present invention, a series of macromolecular antioxidant moieties of the present invention with different chemical structures can be represented by W1H, W2H, W3H, . . . to WnH. In one embodiment of the present invention, two types of antioxidant moieties of the present invention can be represented by: W1H and W2H. In certain embodiments W1H and W2H can have rate constants of k1 and k2 respectively. The reactions involving these moieties and peroxyl radicals can be represented as: [Image Omitted]
where ROO. is a peroxyl radical resulting from, for example, initiation steps involving oxidation activity, for example:
RHâ†’R.+H.â€ƒâ€ƒ(3)
R. +O2â†’ROO.â€ƒâ€ƒ(4)

In one particular embodiment of the present invention k1>>k2 in equations (1) and (2). As a result, the reactions would take place in such a way that there is a decrease in concentration of W1. free radicals due their participation in the regeneration of active moiety W2H in the molecule according equation (5):
W1. +W2Hâ†’W1H+W2. (transfer equilibrium)â€ƒâ€ƒ(5)

This transfer mechanism may take place either in intra- or inter-molecular macromolecules. The transfer mechanism (5) could take place between moieties residing on the same macromolecule (intra-type) or residing on different macromolecules (inter-type).

In certain embodiments of the present invention, the antioxidant properties described immediately above (equation 5) of the macromolecular antioxidants of the present invention result in advantages including, but not limited to:

a) Consumption of free radicals W1, according to equation (5) can result in a decrease of reactions of W1, with hydroperoxides and hydrocarbons (RH).
b) The regeneration of W1H provides extended protection of materials. This is a generous benefit to sacrificial type of antioxidants that are used today.

Regeneration of W1H assists in combating the oxidation process The increase in the concentration of antioxidant moieties W1H (according to equation 5) extends the shelf life of materials.

In certain embodiments of the present invention, the following items are of significant interest for enhanced antioxidant activity in the design of the macromolecular antioxidants of the present invention:

a) The activity of proposed macromolecular antioxidant is dependent on the regeneration of W1 H in equation (5) either through inter- or intra-molecular activities involving homo- or hetero-type antioxidant moieties.
b) Depending on the rates constants of W1H and W2H it is possible to achieve performance enhancements by many multiples and not just incremental improvements.

In certain embodiments of the present invention, more than two types of antioxidant moieties with different rate constants are used in the methods of the present invention.

In certain embodiments, the present invention pertains to the use of the disclosed compounds to inhibit oxidation in an oxidizable material.

For purposes of the present invention, a method of â€œinhibiting oxidationâ€ is a method that inhibits the propagation of a free radical-mediated process. Free radicals can be generated by heat, light, ionizing radiation, metal ions and some proteins and enzymes. Inhibiting oxidation also includes inhibiting reactions caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents of these gases.

As used herein the term â€œoxidizable materialâ€ is any material which is subject to oxidation by free-radicals or oxidative reaction caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents thereof.

Antioxidant compounds of the present invention can be used to prevent oxidation in a wide variety of compositions where free radical mediated oxidation leads to deterioration of the quality of the composition, including edible products such as oils, foods (e.g., meat products, dairy products, cereals, etc.), and other products containing fats or other compounds subject to oxidation. Antioxidant compounds can also be present in plastics and other polymers, elastomers (e.g., natural or synthetic rubber), petroleum products (e.g., fossil fuels such as gasoline, kerosene, diesel oil, heating oil, propane, jet fuel), lubricants, paints, pigments or other colored items, soaps and cosmetics (e.g., creams, lotions, hair products). The antioxidant compounds can be used to coat a metal as a rust and corrosion inhibitor. Antioxidant compounds additionally can protect antioxidant vitamins (Vitamin A, Vitamin C, Vitamin E) and pharmaceutical products from degradation. In food products, the antioxidant compounds can prevent rancidity. In plastics, the antioxidant compounds can prevent the plastic from becoming brittle and cracking.

Antioxidant compounds of the present invention can be added to oils to prolong their shelf life and properties. These oils can be formulated as vegetable shortening or margarine. Oils generally come from plant sources and include cottonseed oil, linseed oil, olive oil, palm oil, corn oil, peanut oil, soybean oil, castor oil, coconut oil, safflower oil, sunflower oil, canola (rapeseed) oil and sesame oil. These oils contain one or more unsaturated fatty acids such as caproleic acid, palmitoleic acid, oleic acid, vaccenic acid, elaidic acid, brassidic acid, erucic acid, nervonic acid, linoleic acid, eleosteric acid, alpha-linolenic acid, gamma-linolenic acid, and arachidonic acid, or partially hydrogenated or trans-hydrogenated variants thereof. Antioxidant compounds of the present invention are also advantageously added to food or other consumable products containing one or more of these fatty acids.

The shelf life of many materials and substances contained within the materials, such as packaging materials, are enhanced by the presence of an antioxidant compound of the present invention. The addition of an antioxidant compound to a packaging material is believed to provide additional protection to the product contained inside the package. In addition, the properties of many packaging materials themselves, particularly polymers, are enhanced by the presence of an antioxidant regardless of the application (i.e., not limited to use in packaging). Common examples of packaging materials include paper, cardboard and various plastics and polymers. A packaging material can be coated with an antioxidant compound (e.g., by spraying the antioxidant compound or by applying as a thin film coating), blended with or mixed with an antioxidant compound, or otherwise have an antioxidant compound present within it.

The entire teachings of each of the following applications are incorporated herein by reference:

Docket No.: 3805.1000-000; Provisional Patent Application No. 60/632,893, filed Dec. 3, 2004, Title: Process For The Synthesis Of Polyalkylphenol Antioxidants, by Suizhou Yang, et al;
Docket No.: 3805.1000-003; patent application Ser. No. 11/292,813, filed Dec. 2, 2005, Title: Process For The Synthesis Of Polyalkylphenol Antioxidants, by Shuzhou Yang, et al;
Docket No.: 3805.1001-000; Provisional Patent Application No. 60/633,197, filed Dec. 3, 2004, Title: Synthesis Of Sterically Hindered Phenol Based Macromolecular Antioxidants, by Ashish Dhawan, et al.;
Docket No.: 3805.1001-003; patent application Ser. No. 11/293,050, filed Dec. 2, 2005, Title: Synthesis Of Sterically Hindered Phenol Based Macromolecular Antioxidants, by Ashish Dhawan, et al.;
Docket No.: 3805.1002-000; Provisional Patent Application No. 60/633,252, filed Dec. 3, 2004, Title: One Pot Process For Making Polymeric Antioxidants, by Vijayendra Kumar, et al.;
Docket No.: 3805.1002-003; patent application Ser. No. 11/293,049, filed Dec. 2, 2005, Title: One Pot Process For Making Polymeric Antioxidants, by Vijayendra Kumar, et al.;
Docket No.: 3805.1003-000; Provisional Patent Application No. 60/633,196, filed Dec. 3, 2004, Title: Synthesis Of Aniline And Phenol-Based Macromonomers And Corresponding Polymers, by Rajesh Kumar, et al.;
Docket No.: 3805.1003-003; patent application Ser. No. 11/293,844, filed Dec. 2, 2005, Title: Synthesis Of Aniline And Phenol-Based Macromonomers And Corresponding Polymers, by Rajesh Kumar, et al.;
Docket No.: 3805.1004-000; Provisional Patent Application No. 60/590,575, filed Jul. 23, 2006, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
Docket No.: 3805.1003-003; patent application Ser. No. 11/293,844, filed Dec. 2, 2005, Title: Synthesis Of Aniline And Phenol-Based Macromonomers And Corresponding Polymers, by Rajesh Kumar, et al.;
Docket No.: 3805.1004-000; Provisional Patent Application No. 60/590,575, filed Jul. 23, 2006, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
Docket No.: 3805.1004-001; Provisional Patent Application No. 60/590,646, filed Jul. 23, 2006, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
Docket No.: 3805.1004-002; patent application Ser. No. 11/184,724, filed Jul. 19, 2005, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
Docket No.: 3805.1004-005; patent application Ser. No. 11/184,716, filed Jul. 19, 2005, Title: Anti-Oxidant Macromonomers And Polymers And Methods Of Making And Using The Same, by Ashok L. Cholli;
Docket No.: 3805.1005-000; Provisional Patent Application No. 60/655,169, filed Feb. 22, 2005, Title: Nitrogen And Hindered Phenol Containing Dual Functional Macromolecules: Synthesis And Their Antioxidant Performances In Organic Materials, by Rajesh Kumar, et al.
Docket No.: 3805.1005-003; patent application Ser. No. 11/360,020, filed Feb. 22, 2006, Title: Nitrogen And Hindered Phenol Containing Dual Functional Macromolecules: Synthesis, Performances And Applications, by Rajesh Kumar, et al.
Docket No.: 3805.1006-000; Provisional Patent Application No. 60/665,638, filed Mar. 25, 2005, Title: Alkylated Macromolecular Antioxidants And Methods Of Making, And Using The Same, by Rajesh Kumar, et al.
Docket No.: 3805.1006-001; patent application Ser. No. 11/389,564, filed Mar. 24, 2006, Title: Alkylated Macromolecular Antioxidants And Methods Of Making, And Using The Same, by Rajesh Kumar, et al.
Docket No.: 3805.1007-000; Provisional Patent Application No. 60/731,125, filed Oct. 27, 2005, Title: Macromolecular Antioxidants And Polymeric Macromolecular Antioxidants, by Ashok L. Cholli, et al.
Docket No.: 3805.1007-001; patent application Ser. No. ______, filed Oct. 27, 2006, Title: Macromolecular Antioxidants And Polymeric Macromolecular Antioxidants, by Ashok L. Cholli, et al.
Docket No.: 3805.1009-000; Provisional Patent Application No. 60/742,150, filed Dec. 2, 2005, Title: Lubricant Oil Composition, by Ashok L. Cholli, et al.
Docket No.: 3805.1010-000; Provisional Patent Application No. 60/731,325, filed Oct. 27, 2005, Title: Stabilized Polyolefin Composition, by Vijayendra Kumar, et al.
Docket No.: 3805.1010-001; patent application Ser. No. ______, filed Oct. 27, 2006, Title: Stabilized Polyolefin Composition, by Vijayendra Kumar, et al.
Docket No.: 3805.1011-000; Provisional Patent Application No. 60/818,876, filed Jul. 6, 2006, Title: Novel Macromolecular Antioxidants Comprising Differing Antioxidant Moieties Structures Methods of Making and Using the Same, by Ashok L. Cholli, et al.
Docket No.: 0813.2006-003; patent application Ser. No. 11/040,193, filed Jan. 21 2005, Title: Post-Coupling Synthetic Approach For Polymeric Antioxidants, by Ashok L. Cholli, et al.;
Docket No.: 0813.2006-002; Patent Application No. PCT/US2005/001948, filed Jan. 21, 2005, Title: Post-Coupling Synthetic Approach For Polymeric Antioxidants, by Ashok L. Cholli et al.;
Docket No.: 0813.2002-008; patent application Ser. No. PCT/US2005/001946, filed Jan. 21, 2005, Title: Polymeric Antioxidants, by Ashok L. Choll, et al.;

In another particular embodiment, the present invention relates to a process for preparing compounds of the present invention. Compounds of the present invention can be prepared by a one pot process, comprising the step of combining a phenol containing compound with a suitable phosphorous containing compound in a suitable solvent under conditions suitable for the reaction of the phenol containing compound with the phosphorous containing compound.

Suitable phenol containing compounds include: [Image Omitted]

where the vales and preferred values for the variables are as described above.

Suitable phosphorous containing compounds are those which are capable of reacting with phenol containing compounds to produce compounds represented by Structural Formula I-III, including, for example, phosphorous trichloride, phosphorous pentachloride, phosphoric acid and phosphoryl trichloride.

Suitable solvents are those which do not contain any acidic protons and dissolve the starting material and the side products, but do not dissolve the end product. Examples of suitable solvents include, for example, dichloromethane, toluene, tetrahydrofuran, dichloromethane, chloroform, dioxane and acetonitrile.

In certain embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs at 25Â° C. In other embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs below 25Â° C. In other embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs at a temperature between 25Â° C. and 0Â° C. In other embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs at a temperature between 15Â° C. and 0Â° C. In other embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs at a temperature between 5Â° C. and 0Â° C. In other embodiments, the reaction of the phenol containing compound with the phosphorous containing compound occurs at 0Â° C.

In certain embodiment, the reaction of the phenol containing compound with the phosphorous containing compound takes place under a nitrogen atmosphere.

In certain embodiments the reaction takes place over 5 hours. In certain other embodiment the reaction takes place in less than 5 hours. In certain other embodiments the reaction takes place in one hour. In certain other embodiment the reaction takes place in less than one hour. In certain other embodiments the reaction takes place for a period of 30 to 40 minutes.

In certain embodiment after completion of the reaction the suitable solvent is removed by distillation

In certain other embodiments after the suitable solvent is distilled off, the compound of the present invention are purified via crystallization using techniques known in the art.

In certain embodiments, after crystallization, the crystals are further filtered and washed using techniques known in the art.

Scheme 1 is a representative example of the synthesis of a compound of the present invention. [Image Omitted]

The macromolecular antioxidant S was synthesized by one pot reaction of phenol with phosphorous trichloride using dichloromethane as a solvent at 0Â° C. The yield of the title compound was more than 95%. [Image Omitted]

The following is an example of one embodiment of the invention and is not to be considered limiting in any way.

In one embodiment the sterically hindered phenol and phosphate based antioxidant is: [Image Omitted]

EXEMPLIFICATION Example 1 Preparation of tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphite, S

A 1 L two-necked round bottom flask equipped with a thermometer, a dropping funnel and a nitrogen inlet was charged with 100 g (0.271 mole) of N-(4-hydroxyphenyl)-3-(2,6-di-tert-butyl, 4-hydroxy phenyl)propionamide, 22 ml (0.271 mole) pyridine in 200 ml of dichloromethane. 7.86 ml(9.033 mmol) of phosphorous trichloride was then added dropwise at a temperature of 0 to 5Â° C. under nitrogen atmosphere for a period of 30 to 40 minutes. After the addition, the funnel was removed and completion of the reaction was checked by TLC/HPLC. After completion, the dichloromethane was distilled out at 40Â° C. To the residue was added 100 ml of methanol to get white crystalline precipitate, which was then filtered and washed several times with cold methanol. The product was characterized by spectroscopic techniques. The melting point is in the range of 224-245Â° C.

Example 2 Stabilization of polypropylene by tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphite S

1000 ppm of S was added to unstabilized polypropylene powder and extruded with single screw extruder in the form wires which was then palletized using a pelletizer. The pelltized sample of polypropylene was subjected to an accelerated oxidative stability test using differential scanning calorimetry (DSC) (ASTM D3895 method).

The results are shown in FIG. 1, which shows that tris [N-(4-hydroxyphenyl),-3-(2,6-di-tert.-butyl, 4-hydroxyphenyl)propionamide]phosphite has a significantly higher oxidative induction time than commercially available IrganoxÂ®.

While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.